Biological E plans to ramp up non-vaccines business in next three years

Hyderabad-based biologics firm Biological E is aiming to grow its non-vaccines business of branded pharmaceutical formulations and complex injectables in the next three years to a sizeable scale.

The privately held company has a turnover of about Rs 1,000 crore, of which close to 70-80 per cent come from the vaccines business now. Biological E aims to take its branded formulations business to a turnover of Rs 1,000 crore by 2025, and the complex injectables business is expected to touch a turnover of Rs 2,000-2,500 crore by that time. The vaccines business, too, will grow in the meanwhile, as the company